Exchange: NASDAQ·Updated 11:09 PM EDT
GERN logo

GERN Geron Corp.

$1.37
$0.02
(1.46%)
Today
Closed $1.35
$0.02
(1.48%)
Overnight
EarningsNov 4
Mkt Cap$867.34M
Vol9.87M

About GERN

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
45

Neutral Sentiment

How do you feel about GERN?

Advertisement|Remove ads.